189 related articles for article (PubMed ID: 14989602)
1. ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus.
Dubelaar EJ; Verwer RW; Hofman MA; Van Heerikhuize JJ; Ravid R; Swaab DE
J Neuropathol Exp Neurol; 2004 Feb; 63(2):159-69. PubMed ID: 14989602
[TBL] [Abstract][Full Text] [Related]
2. Increased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus.
Dubelaar EJ; Mufson EJ; ter Meulen WG; Van Heerikhuize JJ; Verwer RW; Swaab DF
J Neuropathol Exp Neurol; 2006 Mar; 65(3):257-66. PubMed ID: 16651887
[TBL] [Abstract][Full Text] [Related]
3. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent.
Salehi A; Dubelaar EJ; Mulder M; Swaab DF
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11445-9. PubMed ID: 9736756
[TBL] [Abstract][Full Text] [Related]
4. Diminished neuronal metabolic activity in Alzheimer's disease. Review article.
Salehi A; Swaab DF
J Neural Transm (Vienna); 1999; 106(9-10):955-86. PubMed ID: 10599878
[TBL] [Abstract][Full Text] [Related]
5. Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging.
Ishunina TA; Swaab DF
Exp Neurol; 2003 Sep; 183(1):159-72. PubMed ID: 12957499
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
Zhu QB; Unmehopa U; Bossers K; Hu YT; Verwer R; Balesar R; Zhao J; Bao AM; Swaab D
Brain; 2016 Mar; 139(Pt 3):908-21. PubMed ID: 26792551
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease.
Camicioli R; Kaye J; Payami H; Ball MJ; Murdoch G
Dement Geriatr Cogn Disord; 1999; 10(6):437-41. PubMed ID: 10559556
[TBL] [Abstract][Full Text] [Related]
9. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
Glöckner F; Meske V; Ohm TG
Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
[TBL] [Abstract][Full Text] [Related]
10. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
[TBL] [Abstract][Full Text] [Related]
11. Increased CSF cortisol in AD is a function of APOE genotype.
Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA
Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185
[TBL] [Abstract][Full Text] [Related]
12. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.
Arendt T; Schindler C; Brückner MK; Eschrich K; Bigl V; Zedlick D; Marcova L
J Neurosci; 1997 Jan; 17(2):516-29. PubMed ID: 8987775
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
14. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.
Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E
Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238
[TBL] [Abstract][Full Text] [Related]
15. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
16. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease.
Salehi A; Gonzalez Martinez V; Swaab DF
Neurobiol Aging; 1998; 19(6):505-10. PubMed ID: 10192208
[TBL] [Abstract][Full Text] [Related]
17. APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.
Tsuboi Y; Josephs KA; Cookson N; Dickson DW
Neurology; 2003 Jan; 60(2):240-5. PubMed ID: 12552038
[TBL] [Abstract][Full Text] [Related]
18. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease.
Corey-Bloom J; Tiraboschi P; Hansen LA; Alford M; Schoos B; Sabbagh MN; Masliah E; Thal LJ
Neurology; 2000 Jan; 54(2):403-6. PubMed ID: 10668702
[TBL] [Abstract][Full Text] [Related]
19. Does apolipoprotein E (Apo-E) genotype influence nicotinic receptor binding in Alzheimer's disease.
Reid RT; Sabbagh MN; Thal LJ
J Neural Transm (Vienna); 2001; 108(8-9):1043-50. PubMed ID: 11716140
[TBL] [Abstract][Full Text] [Related]
20. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.
Mufson EJ; Ma SY; Cochran EJ; Bennett DA; Beckett LA; Jaffar S; Saragovi HU; Kordower JH
J Comp Neurol; 2000 Nov; 427(1):19-30. PubMed ID: 11042589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
